Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity: A Feasibility Study of the Vigilant App (Vigilant-2)

NCT06675643 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06675643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06675643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity: A Feasibility Study of the Vigilant App (Vigilant-2)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
October 14, 2024
Completion date
March 15, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant skin neoplasm, melanoma